"Oseltamivir" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An acetamido cyclohexene that is a structural homolog of SIALIC ACID and inhibits NEURAMINIDASE.
| Descriptor ID |
D053139
|
| MeSH Number(s) |
D02.065.064.525 D02.455.426.392.368.367.379.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Oseltamivir".
Below are MeSH descriptors whose meaning is more specific than "Oseltamivir".
This graph shows the total number of publications written about "Oseltamivir" by people in this website by year, and whether "Oseltamivir" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2008 | 1 | 2 | 3 |
| 2010 | 3 | 1 | 4 |
| 2011 | 2 | 1 | 3 |
| 2012 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 1 | 2 | 3 |
| 2017 | 13 | 15 | 28 |
| 2018 | 8 | 11 | 19 |
| 2019 | 3 | 6 | 9 |
| 2020 | 6 | 23 | 29 |
| 2021 | 0 | 6 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Oseltamivir" by people in Profiles.
-
Retrospective evaluation of seven different treatment protocols in hospitalized COVID-19 patients Turk J Med Sci. 2021 12 13; 51(6):2835-2849.
-
A nanotechnological approach in the current therapy of COVID-19: model drug oseltamivir-phosphate loaded PLGA nanoparticles targeted with spike protein binder peptide of SARS-CoV-2. Nanotechnology. 2021 Sep 07; 32(48).
-
COVID-19: potential therapeutics for pediatric patients. Pharmacol Rep. 2021 Dec; 73(6):1520-1538.
-
Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group. Antiviral Res. 2021 10; 194:105158.
-
Co-infection of COVID-19 and recurrent malaria. J Infect Dev Ctries. 2021 05 31; 15(5):625-629.
-
Oseltamivir-Induced Mania in a Patient With Influenza A. Clin Neuropharmacol. 2021 May-Jun 01; 44(3):106-107.
-
Nanoparticle composite TPNT1 is effective against SARS-CoV-2 and influenza viruses. Sci Rep. 2021 04 22; 11(1):8692.
-
Treatment profiles and clinical outcomes of COVID-19 patients at private hospital in Jakarta. PLoS One. 2021; 16(4):e0250147.
-
What if COVID-19 affects the child: which weapons and how to use them. Eur Rev Med Pharmacol Sci. 2021 Apr; 25(8):3325-3337.
-
Molecular Docking of Azithromycin, Ritonavir, Lopinavir, Oseltamivir, Ivermectin and Heparin Interacting with Coronavirus Disease 2019 Main and Severe Acute Respiratory Syndrome Coronavirus-2 3C-Like Proteases. J Nanosci Nanotechnol. 2021 04 01; 21(4):2075-2089.